1Christensen, H (2001) What cognitive changes can be expected with normal ageing? Aust N Z J Psychiatry 35, 768–775.
2Anstey, KJ & Low, LF (2004) Normal cognitive changes in aging. Aust Fam Physician 33, 783–787.
3Querfurth, HW & LaFerla, FM (2010) Alzheimer's disease. N Engl J Med 362, 329–344.
4Kelley, BJ & Petersen, RC (2007) Alzheimer's disease and mild cognitive impairment. Neurol Clin 25, 577–609.
5Roth, RM, Isquith, PK & Gioia, GA (2005) Executive function: concepts, assessment and intervention. In Psychologists' Desk Reference, 2nd ed., pp. 38–41 [Koocher, GP, Norcross, JC and Hill, SS, editors]. New York, NY: Oxford University Press.
6Riddle, DR (2007) Brain Aging: Models, Methods, and Mechanisms. Boca Raton, FL: CRC Press.
7Dickstein, DL, Walsh, J, Brautigam, H, et al. (2010) Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med 77, 82–102.
8Mastroeni, D, McKee, A, Grover, A, et al. (2009) Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 4, e6617.
9Graff, J & Mansuy, IM (2009) Epigenetic dysregulation in cognitive disorders. Eur J Neurosci 30, 1–8.
10Wang, SC, Oelze, B & Schumacher, A (2008) Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS One 3, e2698.
11Ford, ES (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28, 2745–2749.
12Frisardi, V, Solfrizzi, V, Seripa, D, et al. (2010) Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 9, 399–417.
13Obunai, K, Jani, S & Dangas, GD (2007) Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 91, 1169–1184, .
14Rumawas, ME, Meigs, JB, Dwyer, JT, et al. (2009) Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort. Am J Clin Nutr 90, 1608–1614.
15Abete, I, Astrup, A, Martinez, JA, et al. (2010) Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev 68, 214–231.
16Poudyal, H, Campbell, F & Brown, L (2010) Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr 140, 946–953.
17Bose, M, Lambert, JD, Ju, J, et al. (2008) The major green tea polyphenol, ( − )-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138, 1677–1683.
18Brown, AL, Lane, J, Coverly, J, et al. (2009) Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 101, 886–894.
19Camargo, A, Ruano, J, Fernandez, JM, et al. (2010) Gene expression changes in mononuclear cells from patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genomics 11, 253.
20Cefalu, WT & Brantley, PJ (2008) Botanicals and cardiometabolic risk: positioning science to address the hype. Metabolism 57, S1–S2.
21Sivaprakasapillai, B, Edirisinghe, I, Randolph, J, et al. (2009) Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism 58, 1743–1746.
22Pinent, M, Blade, MC, Salvado, MJ, et al. (2005) Grape-seed derived procyanidins interfere with adipogenesis of 3T3-L1 cells at the onset of differentiation. Int J Obes (Lond) 29, 934–941.
23Nassiri-Asl, M & Hosseinzadeh, H (2009) Review of the pharmacological effects of Vitis vinifera (grape) and its bioactive compounds. Phytother Res 23, 1197–1204.
26Gu, Y, Nieves, JW, Stern, Y, et al. (2010) Food combination and Alzheimer disease risk: a protective diet. Arch Neurol 67, 699–706.
27Barberger-Gateau, P, Raffaitin, C, Letenneur, L, et al. (2007) Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69, 1921–1930.
28Liebson, PR (2010) Diet, lifestyle, and hypertension and mediterranean diet and risk of dementia. Prev Cardiol 13, 94–96.
29Rayalam, S, Della-Fera, MA & Baile, CA (2008) Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 19, 717–726.
30Borra, MT, Smith, BC & Denu, JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280, 17187–17195.
31Cacciapuoti, F (2008) Opposite effects of metabolic syndrome and calorie restriction on thrombotic disease: head and tail of same coin–resveratrol's role. Metab Syndr Relat Disord 7, 397–400.
32Cherniack, EP (2011) Polyphenols: planting the seeds of treatment for the metabolic syndrome running head: plant polyphenols and the metabolic syndrome. Nutrition 27, 617–623.
33Deng, J-Y & Hung, L-M (2005) Resveratrol improves insulin resistance in high cholesterol-fructose diet Induced metabolic syndrome. In 3rd Annual World Congress on the Insulin Resistance Syndrome, .
34Kim, S, Jin, Y, Choi, Y, et al. (2011) Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol 81, 1343–1351.
35Rocha, KK, Souza, GA, Ebaid, GX, et al. (2009) Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem Toxicol 47, 1362–1367.
36Crandall, JP, Oram, V, et al. (2010) Resveratrol improves glucose metabolism in older adults with IGT. Abstract #736-P. In American Diabetes Association, 70th Scientific Session, .
37Boots, AW, Haenen, GR & Bast, A (2008) Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585, 325–337.
38Egert, S, Bosy-Westphal, A, Seiberl, J, et al. (2009) Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102, 1065–1074.
39Schmatz, R, Mazzanti, CM, Spanevello, R, et al. (2009) Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 610, 42–48.
40Williams, RJ & Spencer, JP (2012) Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 52, 35–45.
41Sakata, Y, Zhuang, H, Kwansa, H, et al. (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224, 325–329.
42Sonmez, U, Sonmez, A, Erbil, G, et al. (2007) Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neurosci Lett 420, 133–137.
43Sharma, M & Gupta, YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71, 2489–2498.
44Kumar, A, Naidu, PS, Seghal, N, et al. (2007) Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79, 17–26.
45Stilling, RM & Fischer, A (2011) The role of histone acetylation in age-associated memory impairment and Alzheimer's disease. Neurobiol Learn Mem 96, 19–26.
46Iraola-Guzman, S, Estivill, X & Rabionet, R (2011) DNA methylation in neurodegenerative disorders: a missing link between genome and environment? Clin Genet 80, 1–14.
47Huber, JL, McBurney, MW, Distefano, PS, et al. (2011) SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183. Future Med Chem 2, 1751–1759.
48Sweatt, JD (2007) Behavioural neuroscience: down memory lane. Nature 447, 151–152.
49Peleg, S, Sananbenesi, F, Zovoilis, A, et al. (2010) Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328, 753–756.
52Shukitt-Hale, B, Lau, FC & Joseph, JA (2008) Berry fruit supplementation and the aging brain. J Agric Food Chem 56, 636–641.
53Joseph, JA, Shukitt-Hale, B & Willis, LM (2009) Grape juice, berries, and walnuts affect brain aging and behavior. J Nutr 139, 1813S–1817S.
54Galli, RL, Bielinski, DF, Szprengiel, A, et al. (2006) Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection. Neurobiol Aging 27, 344–350.
55Joseph, JA, Fisher, DR, Cheng, V, et al. (2008) Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. J Agric Food Chem 56, 10544–10551.
56Joseph, JA, Shukitt-Hale, B, Denisova, NA, et al. (1998) Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 18, 8047–8055.
57Goyarzu, P, Malin, DH, Lau, FC, et al. (2004) Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci 7, 75–83.
58Joseph, JA, Shukitt-Hale, B, Denisova, NA, et al. (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19, 8114–8121.
59Shukitt-Hale, B, Galli, RL, Meterko, V, et al. (2005) Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress. Age 27, 49–57.
60Duffy, KB, Spangler, EL, Devan, BD, et al. (2008) A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats. Neurobiol Aging 29, 1680–1689.
61Joseph, JA, Denisova, NA, Arendash, G, et al. (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153–162.
62Casadesus, G, Shukitt-Hale, B, Stellwagen, HM, et al. (2004) Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7, 309–316.
63Krikorian, R, Shidler, MD, Nash, TA, et al. (2010) Blueberry supplementation improves memory in older adults. J Agric Food Chem 58, 3996–4000.
64Devi, A, Jolitha, AB & Ishii, N (2006) Grape seed proanthocyanidin extract (GSPE) and antioxidant defense in the brain of adult rats. Med Sci Monit 12, BR124–BR129.
65Ono, K, Condron, MM, Ho, L, et al. (2008) Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J Biol Chem 283, 32176–32187.
66Wang, J, Ho, L, Zhao, W, et al. (2008) Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 28, 6388–6392.
67Krikorian, R, Nash, TA, Shidler, MD, et al. (2010) Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr 103, 730–734.
69Crews, WD Jr, Harrison, DW, Griffin, ML, et al. (2005) A double-blinded, placebo-controlled, randomized trial of the neuropsychologic efficacy of cranberry juice in a sample of cognitively intact older adults: pilot study findings. J Altern Complement Med 11, 305–309.
70Shukitt-Hale, B, Cheng, V & Joseph, JA (2009) Effects of blackberries on motor and cognitive function in aged rats. Nutr Neurosci 12, 135–140.
71Shukitt-Hale, B, Kalt, W, Carey, AN, et al. (2009) Plum juice, but not dried plum powder, is effective in mitigating cognitive deficits in aged rats. Nutrition 25, 567–573.
72Tchantchou, F, Chan, A, Kifle, L, et al. (2005) Apple juice concentrate prevents oxidative damage and impaired maze performance in aged mice. J Alzheimers Dis 8, 283–287.
73Rogers, EJ, Milhalik, S, Ortiz, D, et al. (2004) Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice. J Nutr Health Aging 8, 92–97.
74Chan, A & Shea, TB (2009) Dietary supplementation with apple juice decreases endogenous amyloid-beta levels in murine brain. J Alzheimers Dis 16, 167–171.
75Remington, R, Chan, A, Lepore, A, et al. (2010) Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer's disease in an open-label pilot study. Am J Alzheimers Dis Other Demen 25, 367–371.
76Scalbert, A & Williamson, G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S–2085S.
77Bravo, L (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317–333.
78Rossi, L, Mazzitelli, S, Arciello, M, et al. (2008) Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochem Res 33, 2390–2400.
79Del Rio, D, Borges, G & Crozier, A (2010) Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 104, Suppl. 3, S67–S90.
80Crozier, A, Del Rio, D & Clifford, MN (2010) Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31, 446–467.
81Manach, C, Williamson, G, Morand, C, et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S–242S.
82Cottart, CH, Nivet-Antoine, V, Laguillier-Morizot, C, et al. (2010) Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 54, 7–16.